2022
Viral Suppression Levels in Men Who Have Sex With Men and Transgender Women With Newly Diagnosed HIV and Alcohol Use Disorder in Peru: Results From a Randomized, Double-Blind, Placebo-Controlled Trial Using Oral Naltrexone
Gonzales P, Bachireddy C, Grieco A, Ding R, de Leon S, Ulrich A, Lama J, Duerr AC, Altice FL. Viral Suppression Levels in Men Who Have Sex With Men and Transgender Women With Newly Diagnosed HIV and Alcohol Use Disorder in Peru: Results From a Randomized, Double-Blind, Placebo-Controlled Trial Using Oral Naltrexone. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2022, 89: 462-471. PMID: 34897226, PMCID: PMC8881312, DOI: 10.1097/qai.0000000000002889.Peer-Reviewed Original ResearchConceptsMSM/transgender womenAlcohol use disorderOral naltrexoneTransgender womenViral suppressionUse disordersEFV/TDF/FTCTreatment of AUDMaximal viral suppressionSingle treatment regimenPlacebo-controlled trialTDF/FTCAntiretroviral therapy adherenceUse of naltrexoneEvidence-based treatmentsViral suppression levelsMVs levelsSecondary outcomesTherapy adherenceLow adherenceAdherence levelsNaltrexoneAUD treatmentHIVPlacebo
2019
Adherence to HIV treatment regimens: systematic literature review and meta-analysis
Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Preference And Adherence 2019, 13: 475-490. PMID: 31040651, PMCID: PMC6452814, DOI: 10.2147/ppa.s192735.Peer-Reviewed Original ResearchViral suppressionTreatment adherenceAntiretroviral therapySystematic reviewART adherence levelsComplete treatment regimenHigher adherence ratesHuman immunodeficiency virusSuboptimal treatment adherenceHigh treatment adherenceLevel of adherenceObservational settingTablet regimensPill burdenART adherenceRegimen complexityTablet burdenTreatment regimenImmunodeficiency virusAdherence ratesHIV treatmentObservational studyAdherence levelsMeta-AnalysisViral transmission